Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul D Griffiths

Showing results (151-160 of 152) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 152 results.
Lancet (London, England)|April 13, 2011
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialPaul D Griffiths, Anna Stanton, Erin McCarrell, et al.
The New England Journal of Medicine|March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Pageof 16

Showing results (151-160 of 152) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 152 results.
Lancet (London, England)|April 13, 2011
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialPaul D Griffiths, Anna Stanton, Erin McCarrell, et al.
The New England Journal of Medicine|March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Pageof 16